First Hawaiian Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-51,735
| Closed | -$841K | – | 889 |
|
|
2022
Q1 | $841K | Buy |
51,735
+20,970
| +68% | +$341K | 0.03% | 437 |
|
|
2021
Q4 | $426K | Hold |
30,765
| – | – | 0.01% | 679 |
|
|
2021
Q3 | $442K | Sell |
30,765
-10,745
| -26% | -$154K | 0.02% | 557 |
|
|
2021
Q2 | $656K | Sell |
41,510
-3,110
| -7% | -$49.1K | 0.03% | 411 |
|
|
2021
Q1 | $454K | Sell |
44,620
-17,660
| -28% | -$180K | 0.02% | 567 |
|
|
2020
Q4 | $464K | Sell |
62,280
-2,810
| -4% | -$20.9K | 0.02% | 515 |
|
|
2020
Q3 | $224K | Buy |
+65,090
| New | +$224K | 0.01% | 692 |
|